BA
NXTM

Broadview Advisors’s NxStage Medical Inc. NXTM Stock Holding History

Broadview Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-62,256
Closed -$1.51M – 106
2017
Q4 		$1.51M Sell
62,256
-60,675
-49% -$1.6M 0.21% 83
2017
Q3 		$3.39M Sell
122,931
-135,025
-52% -$3.6M 0.49% 67
2017
Q2 		$6.47M Sell
257,956
-143,400
-36% -$3.55M 0.96% 49
2017
Q1 		$10.8M Sell
401,356
-105,800
-21% -$2.92M 1.49% 23
2016
Q4 		$13.3M Buy
507,156
+4,550
+0.9% +$113K 1.78% 19
2016
Q3 		$12.6M Sell
502,606
-99,700
-17% -$2.32M 1.78% 19
2016
Q2 		$13.1M Sell
602,306
-113,100
-16% -$2.02M 1.95% 16
2016
Q1 		$10.7M Sell
715,406
-93,774
-12% -$1.57M 1.54% 22
2015
Q4 		$17.7M Sell
809,180
-262,570
-24% -$4.89M 2.5% 7
2015
Q3 		$16.9M Buy
1,071,750
+5,925
+0.6% +$95K 2.34% 8
2015
Q2 		$15.2M Sell
1,065,825
-177,950
-14% -$3.01M 1.6% 19
2015
Q1 		$21.5M Sell
1,243,775
-393,650
-24% -$6.96M 2.13% 10
2014
Q4 		$29.4M Sell
1,637,425
-23,450
-1% -$378K 2.99% 2
2014
Q3 		$21.8M Buy
1,660,875
+8,450
+0.5% +$114K 2.38% 4
2014
Q2 		$23.7M Sell
1,652,425
-400
-0% -$5.22K 2.31% 6
2014
Q1 		$21.1M Buy
1,652,825
+17,625
+1% +$230K 2.11% 8
2013
Q4 		$16.4M Buy
1,635,200
+297,450
+22% +$3.38M 1.76% 15
2013
Q3 		$17.6M Buy
1,337,750
+414,150
+45% +$5.43M 2.04% 10
2013
Q2 		$13.2M Buy
+923,600
New +$11.6M 1.85% 14

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Broadview Advisors's NXTM Position: Q1 2018 in Review

Broadview Advisors sold out of NxStage Medical Inc. (NXTM) in Q1 2018, closing a stake of 62,256 shares — an estimated $1.51M sold.

Broadview Advisors first reported a position in NXTM in Q2 2013 and held it in 19 quarters. The position peaked at $29.4M in Q4 2014. 168 funds tracked by Wall St. Rank hold NXTM as of Q1 2018.

  • Broadview Advisors reported no remaining NxStage Medical Inc. position as of Q1 2018 after selling out during the quarter.
  • Broadview Advisors sold 62,256 NxStage Medical Inc. shares in Q1 2018, an estimated $1.51M.
  • Broadview Advisors first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 19 quarters.
  • Broadview Advisors's NxStage Medical Inc. position peaked at $29.4M in Q4 2014.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2018.

Based on Broadview Advisors's 13F filing for Q1 2018, filed 11 May 2018.